Latest news
ZNTL260821P00002500 interactive stock chart | ZNTL Aug 2026 2.500 put stock - Yahoo Finance SingaporeYahoo Finance Singapore · Sun, 09 Aug 2026 17:43:22 GMTZNTL Stock Rallies To Near 22-Month Highs – An Analyst Sees Further 56% Upside After A Crucial Trial Update - StocktwitsStocktwits · Sat, 08 Aug 2026 06:32:17 GMTZentalis Pharmaceuticals (NASDAQ:ZNTL) Cut to Strong Sell at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 05:18:56 GMTMorgan Stanley Maintains Zentalis Pharmaceuticals(ZNTL.US) With Hold Rating, Raises Target Price to $5 - MoomooMoomoo · Sat, 08 Aug 2026 03:45:33 GMTH.C. Wainwright Maintains Zentalis Pharmaceuticals(ZNTL.US) With Buy Rating, Maintains Target Price $10 - MoomooMoomoo · Sat, 08 Aug 2026 03:38:32 GMTWedbush Adjusts Price Target on Zentalis Pharmaceuticals to $5 From $4, Maintains Neutral Rating - MoomooMoomoo · Fri, 07 Aug 2026 20:53:39 GMTZNTL Advances Clinical Trials for Ovarian Cancer Drug Amid Valua - GuruFocusGuruFocus · Thu, 06 Aug 2026 23:38:12 GMTZNTL: Q2 2026 net loss widened to $42.3M as R&D spending rose for late-stage azenosertib trials - tradingview.comtradingview.com · Thu, 06 Aug 2026 20:18:19 GMT